Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Lapatinib | Lapatinib, used in the form of Lapatinib Ditosylate, is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively. Uses: Antineoplastic agents; protein kinase inhibitors. Group: Pharmaceutical. CAS No. 231277-92-2. Pack Sizes: 1 g. Product ID: NP3214. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Lapatinib Ditosylate | Lapatinib is a synthetic, orally-active quinazoline with potential antineoplastic activity. Lapatinib reversibly blocks phosphorylation of the epidermal growth factor receptor (EGFR), ErbB2, and the Erk-1 and-2 and AKT kinases; it also inhibits cyclin D protein levels in human tumor cell lines and xenografts. EGFR and ErbB2 have been implicated in the growth of various tumor types. Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 388082-77-7. Pack Sizes: 1 g. Product ID: B0084-067756. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lapatinib ditosylate monohydrate | 100mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C29H26ClFN4O4S ·2(C7H8O3S) ·H2O. CAS No. 388082-78-8. Prepack ID : 13289809-100mg. Molecular Weight : 943.48. |  |
| Lapatinib Hydroxylamine | a complex used in human metabolism of lapatinib which is a dual kinase inhibitor. Group: Pharmaceutical. CAS No. 1360431-86-2. Pack Sizes: 10 mg. Product ID: B2694-473628. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lapatinib Impurities | Lapatinib Impurities are crucial analytical reference materials used in the biomedical industry to ensure the safety, potency, and efficacy of Lapatinib, a tyrosine kinase inhibitor. Lapatinib is primarily prescribed for treating HER2-positive breast cancer. These impurities aid in the comprehensive understanding of the drug's pharmacokinetics and stability profile. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
